Telepsychiatry in Children: Diagnostic Evaluation of Autism Spectrum Disorder
Recruiting
N/A
Interventional Study
Autism Spectrum Disorder (ASD)
Neurodevelopmental Disorders
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 2 – 5
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 137 (estimated)
- Sponsor
- Centre Hospitalier St Anne · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder recognized as a major national cause in 2012. The French Autism Plan 2018-2022 emphasizes early diagnosis and intervention for better cognitive and behavioral outcomes. The COVID-19 pandemic complicates the use of the ADOS-2 diagnostic tool due to mask-wearing and distancing requirements. To address this, the Brief Observation Symptom…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Children aged 24 months to 5 years whose families request a diagnostic evaluation at the Autism and Related Disorders Research and Diagnostic Center (CREDAT).
* Consent to participate in the research in addition to their planned evaluation at the Autism and Related Disorders R…
Contacts